Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.

Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...

Pharma giant Eli Lilly may plant a $5.9 billion manufacturing facility in Houston’s Generation Park, bringing serious biotech ...

Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...

CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA ...

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...

Houston's life sciences market was waiting for demand to catch up to new supply. Now, threats to federal research funding ...

The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting.

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.